Requip Xl 4 Mg Prolonged-Release Tablets
4
PATIENT INFORMATION LEAFLET
REQUIP® XL 2 mg PROLONGED-RELEASE TABLETS/
REQUIP® XL 4 mg PROLONGED-RELEASE TABLETS Revision date: 16 05 2016
REQUIP® XL 8 mg PROLONGED-RELEASE TABLETS Ref REQXL 248 s
ropinirole (as hydrochloride)
Your medicine is known by the above names, but will be referred to as Requip® XL throughout this leaflet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, nurse specialist or pharmacist.
This medicine has been prescribed for you only.
Don’t pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Requip® XL is and what it is used for
2. What you need to know before you take Requip® XL
3. How to take Requip® XL
4. Possible side effects
5. How to store Requip® XL
6. Contents of the pack and other information
1. WHAT REQUIP® XL IS AND WHAT IT IS USED FOR Requip® XL is used to treat Parkinson’s disease.
The active ingredient in Requip® XL is ropinirole, which belongs to a group of medicines called dopamine agonists. Dopamine agonists affect the brain in a similar way to a natural substance called dopamine.
People with Parkinson’s disease have low levels of dopamine in some parts of their brains. Ropinirole has effects similar to those of natural dopamine, so it helps to reduce the symptoms of Parkinson’s disease. You can take Requip® XL (like Requip®) either on its own or along with L-dopa (see section 4 of this leaflet for more details). Requip® XL should be prescribed and your progress monitored by a doctor with experience in the treatment of Parkinson’s disease.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE REQUIP® XL
Do not take Requip® XL:
• if you are allergic to ropinirole or any of the other ingredients of this medicine (listed in section 6)
• if you have serious kidney disease
• if you have liver disease
->Tell your doctor or nurse if you think any of these may apply to you.
Warnings and Precautions
Talk to your doctor or pharmacist before taking Requip® XL:
• if you are pregnant or think you may be pregnant
• if you are breast-feeding
• if you are under 18 years old
• if you have a serious heart complaint
• if you have a history of or currently have a serious mental health problem
• if you have a history of or have experienced any unusual urges and/or behaviours (such as excessive gambling or excessive sexual behaviour, see section 4)
• if you have an intolerance to some sugars (such as lactose).
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to adjust or stop your dose.
->Tell your doctor or nurse if you think any of these may apply to you. Your doctor or nurse may decide that Requip® XL isn’t suitable for you, or that you need extra check-ups while you’re taking it.
You also need to be careful with Requip® XL if you drive or operate machinery. Please read the warning in section 3 of this leaflet.
Other medicines and Requip® XL
Tell your doctor, nurse or pharmacist if you are taking, have recently taken, or might take any other medicines- including any herbal remedies or medicines you bought without a prescription.
Some medicines can affect the way Requip® XL works, or make it more likely that you’ll have side effects. Requip® XL can also affect the way some other medicines work.
These include:
• the anti-depressant, fluvoxamine
• HRT (hormone replacement therapy)
• medication for other mental health problems, for example sulpiride
• metoclopramide, which is used to treat nausea and heartburn
• cimetidine, used in the treatment of stomach ulcers
• the antibiotics, ciprofloxacin or enoxacin
• any other medicine for Parkinson's disease.
->Tell your doctor or nurse if you’re taking, or have recently taken, any of these.
Remember to tell your doctor or nurse if you start taking any other medicine while you’re taking Requip® XL.
ReQuip XL with food and drink
You can take Requip® XL with or without food, as you prefer. Because high fat foods might increase the amount of ropinirole absorbed by your body, it is recommended that you do not take Requip® XL at the same time as a high fat meal.
Pregnancy and breast-feeding
Requip® XL is not recommended if you are pregnant, unless your doctor advises that the benefit of you taking Requip® XL is greater than the risk to your unborn baby.
Requip® XL is not recommended if you are breast-feeding, as it
can affect your milk production.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Requip® XL can make you feel drowsy or dizzy.
It can make people feel extremely sleepy, and it sometimes makes people fall asleep very suddenly without warning.
If you could be affected: don’t drive, don’t operate machines and don’t put yourself in any situation where feeling sleepy or falling asleep could put you (or other people) at risk of serious injury or death. Don’t take part in these activities until you are sure you’re not affected.
->Talk to your doctor or nurse if this causes problems for you.
Requip® XL contains lactose and sunset yellow
Requip® XL tablets contain a sugar called lactose. If you have been told that you have an intolerance to some sugars, contact your doctor or nurse before taking Requip® XL.
The 4 mg tablets contain a colouring called sunset yellow (E110), which may cause allergic reactions.
Smoking and ReQuip XL
Tell your doctor or nurse if you start smoking, or give up smoking, while you’re taking Requip® XL. Your doctor or nurse may need to adjust your dose.
3. HOW TO TAKE REQUIP® XL
Always take this medicine exactly as your doctor or nurse or pharmacist has told you. Check with your doctor, nurse or pharmacist if you are not sure.
Do not give Requip® XL to children. Requip® XL is not normally prescribed for people under 18.
You may be given Requip® XL on its own to treat the symptoms of your Parkinson’s disease. Or you may be given Requip® XL as well as another medicine called L-dopa (also called levodopa). Requip® XL should be prescribed and your progress monitored by a doctor with experience in the treatment of Parkinson’s disease.
If you are taking L-dopa you may experience some uncontrollable movements (dyskinesias) when you first start taking Requip® XL. Tell your doctor if this happens, as your doctor may need to adjust the dose of the medicines you are taking.
Tell your doctor if you or your family notices that you are developing any unusual behaviours (such as an unusual urge to gamble or increased sexual urges and/or behaviours) while you are taking Requip® XL. Your doctor may need to adjust your dose.
If you are switching from Requip® film-coated (immediate-release) tablets
Your doctor or nurse will base your dose of Requip® XL on the dose of Requip® you were taking. You will take the same or similar daily dose of Requip® XL to your previous dose of Requip® but you will only take Requip® XL once a day.
Take your Requip® as normal the day before you switch. Then take your Requip® XL on the next day and don’t take any more Requip®. Your doctor or nurse will be monitoring your progress closely after switching to Requip® XL. If there is any change in the control of your symptoms before your next appointment, talk to your doctor or nurse as soon as possible in case dose adjustment is needed.
How much Requip® XL will you need to take?
It may take a while to find out the best dose of Requip® XL for you.
The recommended starting dose of Requip® XL tablets is 2 mg once daily for the first week. Your doctor may increase your dose to 4 mg of Requip® XL tablets once daily, from the second week of treatment. If you are very elderly your doctor may increase your dose more slowly. After that, the doctor may adjust your dose until you are taking the dose that is best for you. Some people take up to 24 mg of Requip® XL tablets each day.
If at the start of your treatment, you experience side effects that you find difficult to tolerate, speak to your doctor. Your doctor may advise you to switch to a lower dose of Requip® film-coated (immediate-release) tablets which you will take three times a day.
Don’t take more Requip® XL than your doctor or nurse has recommended.
It may take a few weeks for Requip® XL to work for you.
Taking your dose of Requip® XL
Take Requip® XL once a day, at the same time each day.
Swallow your Requip® XL tablets whole, with a glass of water.
Don’t break, chew or crush the tablets - if you do, there’s a danger you could overdose, because the medicine will be released into your body too quickly.
Requip® XL tablets are designed to release the drug into your body over a 24 hour period. If the tablets pass through your body in less than 24 hours, the medicine may not be completely released. You may see tablets in your stool. If this happens, let your doctor know.
If you take more Requip® XL than you should
Contact a doctor, nurse or pharmacist immediately. If possible, show them the Requip® XL pack.
Someone who has taken an overdose of Requip® XL may have any of these symptoms: feeling sick (nausea), being sick (vomiting), dizziness (a spinning sensation), feeling drowsy, mental or physical tiredness, fainting, hallucinations.
If you forget to take Requip® XL
Do not take a double dose to make up for a forgotten dose.
If you have missed taking Requip® XL for one day or more, ask
your doctor or nurse for advice on how to start taking it again.
If you stop taking Requip® XL
Don’t stop taking Requip® XL without advice.
Take Requip® XL for as long as your doctor or nurse recommends. Don’t stop unless your doctor or nurse advises you to.
If you suddenly stop taking Requip® XL, your Parkinson’s disease symptoms may quickly get much worse. A sudden stop could cause you to develop a medical condition called neuroleptic malignant syndrome which may represent a major health risk. The symptoms include: akinesia (loss of muscle movement), rigid muscles, fever, unstable blood pressure, tachycardia (increased heart rate), confusion, drepressed level of consciousness (e.g. coma).
If you need to stop taking Requip® XL, your doctor or nurse will reduce your dose gradually.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can have side effects, but not everyone gets them.
The more common side effects of Requip® XL are more likely to happen when you first start taking it, or when your dose has just been increased. They are usually mild, and may become less troublesome after you’ve taken the dose for a while. If you’re worried about side effects, talk to your doctor or nurse.
Very common side effects:
may affect more than 1 in 10 people
• fainting
• feeling drowsy
• feeling sick (nausea).
Common side effects:
may affect up to 1 in 10 people
• hallucinations (sensing things that are not real)
• being sick (vomiting)
• feeling dizzy (a spinning sensation)
• heartburn
• stomach pain
• constipation
• swelling of the legs, feet or hands.
Uncommon side effects:
may affect up to 1 in 100 people
• feeling dizzy or faint, especially when you stand up suddenly (this is caused by a drop in blood pressure)
• feeling very sleepy during the day
• falling asleep very suddenly without feeling sleepy first (sudden sleep onset episodes)
• mental problems such as delirium (severe confusion), delusions (unreasonable ideas) or paranoia (unreasonable suspicions).
You may experience the following side effects (frequency not known):
• inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
• strong impulse to gamble excessively despite serious personal or family consequences
• altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive
• uncontrollable excessive shopping or spending
• binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger).
->Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or reducing the symptoms
Very rare side effects:
may affect up to 1 in 10,000 people
A very small number of people taking Requip® XL (less than 1 in 10,000) have experienced:
• changes in liver function, which have shown up in blood tests
• allergic reactions such as red, itchy swellings on the skin (hives), swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing, rash or intense itching.
Some patients may have the following side effects (frequency not known: cannot be estimated from the available data)
• act in an aggressive manner
• excessive use of Requip® XL (craving for large doses of dopaminergic drugs in excess of that required to control motor symptoms, known as dopamine dysregulation syndrome)
If you’re taking Requip® XL with L-dopa
People who are taking Requip® XL with L-dopa may develop other side effects over time:
• uncontrollable movements (dyskinesias) are a very common side effect. If you are taking L-dopa you may experience some uncontrollable movements (dyskinesias) when you first start taking Requip® XL. Tell your doctor if this happens, as your doctor may need to adjust the dose of the medicines you are taking.
• feeling confused is a common side effect.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE REQUIP® XL
Keep Requip® XL out of the sight and reach of children.
Don’t use Requip® XL after the expiry date shown on the carton label. Do not store above 25°C. Store in the original package.
If you have any unwanted Requip® XL tablets, don’t dispose of them in waste water or household rubbish. Take them back to your pharmacist, who will dispose of them in a way that won’t harm the environment.
If your tablets show signs of deterioration or discolouration, seek the advice of your pharmacist who will tell you what to do.
6. CONTENTS OF THE PACK AND OTHER INFORMATION What Requip® XL contains
Each prolonged-release tablet contains 2mg, 4mg or 8mg of ropinirole (as hydrochloride).
Each tablet also contains hypromellose, hydrogenated castor oil, carmellose sodium, povidone (K29-32), maltodextrin, magnesium stearate, lactose monohydrate, colloidal anhydrous silica, mannitol (E421), yellow iron oxide (E172), glycerol dibehenate, titanium dioxide (E171), and macrogol 400.
The 2mg tablets also contain red iron oxide (E172).
The 4mg tablets also contain sunset yellow (E110) and indigo carmine aluminium lake (E132).
The 8mg tablets also contain red iron oxide (E172) and black iron oxide (E172).
What Requip® XL looks like and contents of the pack
Requip® XL 2 mg Prolonged-Release Tablets are pink, capsule shaped, marked ‘3V2’ on one side and ‘GS’ on the other side.
Requip® XL 4 mg Prolonged-Release Tablets are light brown, capsule shaped, marked ‘WXG’ on one side and ‘GS’ on the other side.
Revision date: 16.05.2016 Ref: REQXL 2,4,8 S
A number of groups exist to provide further information and support to Parkinson's disease patients and their carers. The main one is the Parkinson's Disease Society, who you can contact at the address given below:
Parkinson's Disease Society 215 Vauxhall Bridge Road London SW1V1EJ
Requip® is a registered trademark of the GlaxoSmithKline group of companies
Requip® XL 8 mg Prolonged-Release Tablets are red, capsule shaped, marked ‘5CC’ on one side and ‘GS’ on the other side.
Requip® XL is available in blister packs of 28 tablets.
Who manufactured your medicine
Manufactured by Glaxo Wellcome S.A., Avenida de Extremadura 3, 09400 Aranda de Duero, Burgos Spain. Procured from within the EU and repackaged by Product Licence Holder: Beachcourse Limited, 20 Alliance Court, London W3 ORB.
Requip® XL 2 mg Prolonged-Release Tablets PL 16378/0535 |POM| Requip® XL 4 mg Prolonged-Release Tablets PL 16378/0536 Requip® XL 8 mg Prolonged-Release Tablets PL 16378/0537
3